N/A
Completed N=66
RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)
Source: ClinicalTrials.gov NCT02246660 ↗Enrolled (actual)
66
Serious AEs
12.1%
Results posted
Apr 2018
Primary outcomePrimary: 6-Minute Walk Distance, Meters — -12.8; 4.6; -12.3 meters
Summary
The RESTORE trial will determine whether resveratrol supplementation can improve walking performance in older people with lower extremity peripheral arterial disease (PAD). Resveratrol, a polyphenol and natural supplement, specifically targets several impairments associated with walking difficulty and mobility loss in people with PAD.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY 6-Minute Walk Distance, Meters |
-12.8; 4.6; -12.3 | — |
Eligibility Criteria
Inclusion Criteria
- Ankle-brachial index (ABI) 1,600 feet )
- Treated for cancer during the last 2 years (unless prognosis is excellent)
- Severe hearing impairment or other communication difficulties (e.g. non-English speaking) or legally blind
- Diagnosis of Parkinson's disease
- Unable to return to medical center at required visit frequency
- Otherwise poorly suited to intervention (at the discretion of the PI)
Data sourced from ClinicalTrials.gov (NCT02246660). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.